Low-dose aspirin recall due to improper storage temperature conditions
Cardinal Healthcare is recalling low-dose aspirin tablets nationwide due to a CGMP deviation involving improper storage temperatures. Products may have been exposed to conditions outside the manufacturer's labeled storage requirements, potentially affecting product stability.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for a CGMP deviation involving exposure to improper storage temperatures. No illnesses, injuries, or hospitalizations are reported in the source. The hazard is theoretical—improper storage could affect drug stability and efficacy—but without documented adverse health effects, it meets the criteria for High severity.
Plain-English summary
Cardinal Healthcare is recalling Low Dose Aspirin 81 mg tablets (batch P126201) nationwide due to a Good Manufacturing Practice (CGMP) deviation. The products were exposed to temperatures outside of the labeled storage conditions, which could affect product stability and efficacy.
The affected product is a 120 tablet bottle of enteric-coated aspirin distributed by Rugby Laboratories. The batch number P126201 with NDC 0536-1234-41 has been identified as part of this recall. The recall is nationwide.
Consumers who have purchased this product should consult with a pharmacist or healthcare provider about the affected batch. Check your medication bottle for batch number P126201 and the recalled NDC number. Ask your pharmacist about proper disposal methods.
The recalled product
- Product
- ASPIRIN (ASPIRIN)
- Brand
- ASPIRIN
- Manufacturer
- CARDINAL HEALTHCARE
- Category
- Drug — OTC Medication
- Hazard
- temperature-deviation
- stability-concern
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch P126201
UPCs (1)
- 0305361234416
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ASPIRIN
- ModerateAspirin 81 mg chewable tablets recalled due to packaging defect
FDA (Drugs) · 2024-11-27
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27